MOBIA MEDICAL, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MOBIA MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $181.00K, a 1545.45% increase year-over-year.
- MOBIA MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $358.00K, a 69.67% increase year-over-year.
- MOBIA MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $11.00K.
- MOBIA MEDICAL, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $211.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $181.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $358.00K 10-Q · filed 2026-08-11 | |
| 2025-06-30 | $11.00K 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $211.00K 10-Q · filed 2026-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B |